CorMedix Inc. Files 8-K on Operations and Financials
Ticker: CRMD · Form: 8-K · Filed: Apr 8, 2025 · CIK: 1410098
| Field | Detail |
|---|---|
| Company | Cormedix Inc. (CRMD) |
| Form Type | 8-K |
| Filed Date | Apr 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, operations, sec-filing
Related Tickers: CRMD
TL;DR
CRMD filed an 8-K for routine financial and operational updates.
AI Summary
CorMedix Inc. filed an 8-K on April 8, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing does not contain specific financial figures or operational updates beyond the reporting of these standard sections.
Why It Matters
This filing indicates CorMedix Inc. is providing standard updates on its financial condition and operations to the SEC, which is a routine but necessary disclosure for public companies.
Risk Assessment
Risk Level: low — This is a standard 8-K filing reporting on financial condition and operations, without any specific negative or positive material events disclosed.
Key Players & Entities
- CorMedix Inc. (company) — Registrant
- April 8, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-34673 (filing_id) — Commission File Number
- 20-5894890 (ein) — I.R.S. Employer Identification No.
- 300 Connell Drive , Suite 4200 Berkeley Heights , NJ 07922 (address) — Principal executive offices
- (908) 517-9500 (phone) — Registrant's telephone number
FAQ
What specific financial results or operational updates are detailed in this 8-K filing?
The filing indicates it covers 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits,' but does not provide specific figures or details within the provided text.
When was this 8-K report filed?
The report was filed on April 8, 2025.
What is the primary purpose of this 8-K filing for CorMedix Inc.?
The primary purpose is to report on the company's results of operations and financial condition, along with financial statements and exhibits.
Where is CorMedix Inc. headquartered?
CorMedix Inc.'s principal executive offices are located at 300 Connell Drive, Suite 4200, Berkeley Heights, NJ 07922.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 8, 2025 regarding CorMedix Inc. (CRMD).